학술논문
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer
Document Type
Article
Author
Source
In: Cancer Science . (Cancer Science, August 2022, 113(8):2814-2827)
Subject
Language
English
ISSN
13497006
13479032
13479032